| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |